The audiogram has been used to determine whether someone needs hearing help and whether they would benefit from a hearing aid. The fact that only 30% of those with a measurable hearing loss (PTA > 25 dB HL) has been used repeatedly to indict the hearing aid industry for not helping the 70% of those with a hearing loss who are presumed to need hearing help.
In Australia, this evaluation has often been based on how many hearing aids are sold over a period of time. The consensus signals a shift towards a more client-centric measurement of rehabilitation success. This has been achieved by considering factors that are meaningful to people who receive hearing rehabilitation services and represent the genuine positive impact that hearing rehabilitation has on their day-to-day lives.
In an announcement, Hearing Australia encourages parents to check their child’s hearing health to...
HR Editor Karl Strom considers what the FDA can do in the wake of its recent GMP workshop, the PCAST recommendations, and impending report from the IOM. Would these proposals lead to more innovation, affordability and accessibility for consumers…or represent a giant step backward?
Read More
The FDA announced that it is allowing the marketing of a new hearing aid that uses a laser diode and direct vibration of the eardrum to amplify sound: the EarLens Contact Hearing Device (CHD), which is manufactured by EarLens Corp, Menlo Park, Calif.
Read More
According to Brent Edwards, PhD, if we are to fully understand patient treatment, we must now consider the relationship between cognitive function and hearing ability, and the relationship between cognitive function and hearing aid technology.
Read More
Brent Edwards, PhD, former vice-president of research for Starkey Hearing Technologies and a key person behind the establishment of the Starkey Hearing Research Center in Berkeley, Calif, has accepted the position of chief technology officer at EarLens Corp.
Read More